EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

The Prevalence of CYP2C19 Polymorphism in Patients with Symptomatic Intracranial Atherosclerosis

Songchai Kittipanprayoon, Pongpat Vorasayan, Aurauma Chutinet, Pajaree Chariyavilaskul, Nijasri C Suwanwela

Cerebrovascular Diseases Extra · 02.01.2025 · 15 (1) · 68-72

DOI: 10.1159/000543331 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cerebrovascular Diseases Extra, online erschienen am 02.01.2025. Verfasst von Songchai Kittipanprayoon und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Hatyai Hospital, Songkhla, Thailand. Hauptthemen laut MEDLINE: Cytochrome P-450 CYP2C19, Intracranial Arteriosclerosis, Polymorphism, Genetic, Pharmacogenomic Variants. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Clopidogrel and aspirin were proved to have benefit in symptomatic intracranial stenosis. CYP2C19 polymorphism (CYP2C19*1, CYP2C19*2, CYP2C19*3, and CYP2C19*17 alleles) affects efficacy of clopidogrel. Epidemiologic study of CYP2C19 polymorphism has been conducted in Thai population. There was no data showed the frequency of allelic variants of CYP2C19 in Thai symptomatic intracranial stenosis patients. The aim of this study was to determine the prevalence of CYP2C19 polymorphism in symptomatic intracranial stenosis patients.

Methods

The study group included 100 Thai symptomatic intracranial stenosis patients. Genotyping of CYP2C19 alleles (CYP2C19*1, CYP2C19*2, CYP2C19*3, and CYP2C19*17 alleles) was carried out by real-time polymerase chain reaction (rt-PCR) technique.

Results

The allele frequency of CYP2C19*1, CYP2C19*2, CYP2C19*3, and CYP2C19*17 were 70.5%, 26%, 2.5%, and 1%, respectively. The result showed that 53% of symptomatic intracranial stenosis patients are normal metabolizers, while intermediate and poor metabolizer were 36 and 10 percent, respectively.

Conclusion

Almost one-half of Thai symptomatic intracranial stenosis patients were intermediate or poor metabolizers. Usage of combination of aspirin and clopidogrel might not be effective in this group of patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cytochrome P-450 CYP2C19Intracranial ArteriosclerosisPolymorphism, GeneticPharmacogenomic VariantsHumansMaleFemaleMiddle AgedThailandGene FrequencyPlatelet Aggregation InhibitorsAgedClopidogrelPrevalencePhenotypeAspirinAdultGenetic Predisposition to Disease

Stichwörter der Autor:innen

CYP2C19 polymorphismClopidogrelIschemic strokeSymptomatic intracranial stenosis

Substanzen

Cytochrome P-450 CYP2C19CYP2C19 protein, humanPlatelet Aggregation InhibitorsClopidogrelAspirin

Autor:innen und Institutionen

  • Department of Medicine, Hatyai Hospital, Songkhla, Thailand.
  • Chulalongkorn Stroke Center, King Chulalongkorn Memorial Hospital, Bangkok, Thailand, pongpatv@yahoo.com.
  • Chulalongkorn Stroke Center, King Chulalongkorn Memorial Hospital, Bangkok, Thailand.
  • Department of Pharmacology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
  • Division of Neurology, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.

Zitieren

APA

Kittipanprayoon, S., Vorasayan, P., Chutinet, A., Chariyavilaskul, P., & Suwanwela, N. C. (2025). The Prevalence of CYP2C19 Polymorphism in Patients with Symptomatic Intracranial Atherosclerosis. Cerebrovascular Diseases Extra, 15(1), 68-72. https://doi.org/10.1159/000543331

Vancouver

Kittipanprayoon S, Vorasayan P, Chutinet A, Chariyavilaskul P, Suwanwela NC. The Prevalence of CYP2C19 Polymorphism in Patients with Symptomatic Intracranial Atherosclerosis. Cerebrovascular Diseases Extra. 2025;15(1):68-72. doi:10.1159/000543331

BibTeX
@article{Kittipanprayoon2025,
  author = {Kittipanprayoon, Songchai and Vorasayan, Pongpat and Chutinet, Aurauma and Chariyavilaskul, Pajaree and Suwanwela, Nijasri C},
  title = {The Prevalence of CYP2C19 Polymorphism in Patients with Symptomatic Intracranial Atherosclerosis},
  journal = {Cerebrovascular Diseases Extra},
  year = {2025},
  volume = {15},
  number = {1},
  pages = {68--72},
  doi = {10.1159/000543331}
}
Kostenlos starten →